These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33463126)

  • 21. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis.
    Melo AKG; Milby KM; Caparroz ALMA; Pinto ACPN; Santos RRP; Rocha AP; Ferreira GA; Souza VA; Valadares LDA; Vieira RMRA; Pileggi GS; Trevisani VFM
    PLoS One; 2021; 16(6):e0253894. PubMed ID: 34185801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A biomarker based severity progression indicator for COVID-19: the Kuwait prognosis indicator score.
    Jamal MH; Doi SA; AlYouha S; Almazeedi S; Al-Haddad M; Al-Muhaini A; Al-Ghimlas F; Chowdhury ME; Al-Sabah S
    Biomarkers; 2020 Dec; 25(8):641-648. PubMed ID: 33090050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of interleukin-6 and procalcitonin in patients with periprosthetic joint infection: a systematic review and meta-analysis.
    Yoon JR; Yang SH; Shin YS
    Int Orthop; 2018 Jun; 42(6):1213-1226. PubMed ID: 29294147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
    Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis.
    Yamada T; Wakabayashi M; Yamaji T; Chopra N; Mikami T; Miyashita H; Miyashita S
    Clin Chim Acta; 2020 Oct; 509():235-243. PubMed ID: 32533986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of clinical parameters in predicting the severity of COVID-19.
    Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
    J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19.
    Wungu CDK; Khaerunnisa S; Putri EAC; Hidayati HB; Qurnianingsih E; Lukitasari L; Humairah I; Soetjipto
    Int J Infect Dis; 2021 Apr; 105():551-559. PubMed ID: 33711519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.
    Hariyanto TI; Japar KV; Kwenandar F; Damay V; Siregar JI; Lugito NPH; Tjiang MM; Kurniawan A
    Am J Emerg Med; 2021 Mar; 41():110-119. PubMed ID: 33418211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic test accuracy of serum procalcitonin compared with C-reactive protein for bone and joint infection in children and adolescents: a systematic review and meta-analysis.
    Ritchie B; Porritt K; Marin T; Williams N
    JBI Evid Synth; 2021 Dec; 19(12):3209-3237. PubMed ID: 34402489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of procalcitonin in adult non-neutropenic cancer patients with suspected infection: a systematic review and meta-analysis.
    Lee YC; Yeh HT; Lu SW; Tsai YC; Tsai YC; Yen CC
    BMC Infect Dis; 2024 Mar; 24(1):278. PubMed ID: 38438974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of Immune-Inflammatory Index in PSI IV-V Patients with COVID-19.
    Han R; Su H; Guo G; Wang Q; Ma J; Li Z; Huang S; Ni Y; Hu R; Huang D; Zhou H
    Biomed Res Int; 2021; 2021():9987931. PubMed ID: 34423043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID-19.
    Horiuchi Y; Hayashi F; Iwasaki Y; Matsuzaki A; Nishibe K; Kaniyu K; Marutani S; Saito K; Matsuoka S; Uchihashi K; Miida T; Ai T; Tabe Y
    Int J Lab Hematol; 2021 Dec; 43(6):1309-1318. PubMed ID: 34523805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update of biomarkers to diagnose diabetic foot osteomyelitis: A meta-analysis and systematic review.
    Ansert EA; Tarricone AN; Coye TL; Crisologo PA; Truong D; Suludere MA; Lavery LA
    Wound Repair Regen; 2024; 32(4):366-376. PubMed ID: 38566503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers.
    Tjendra Y; Al Mana AF; Espejo AP; Akgun Y; Millan NC; Gomez-Fernandez C; Cray C
    Arch Pathol Lab Med; 2020 Dec; 144(12):1465-1474. PubMed ID: 32818235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection.
    Heer RS; Mandal AK; Kho J; Szawarski P; Csabi P; Grenshaw D; Walker IA; Missouris CG
    Ann Clin Biochem; 2021 Sep; 58(5):520-527. PubMed ID: 34018843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19.
    Barrett B; Pamphile S; Yang F; Naeem F; Kim J; Annam J; Borczuk R; Yellin S; Bass C; Fowler S; Mosheyev M; Mayer YJ; Friedman BW
    Am J Emerg Med; 2021 Aug; 46():595-598. PubMed ID: 33280969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or "just" a marker of bacterial coinfection?
    Lugito NPH
    Curr Res Transl Med; 2021 May; 69(2):103289. PubMed ID: 33845428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis.
    Liu D; Su L; Han G; Yan P; Xie L
    PLoS One; 2015; 10(6):e0129450. PubMed ID: 26076027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19.
    Zeng Z; Hong XY; Li Y; Chen W; Ye G; Li Y; Luo Y
    Biomark Med; 2020 Dec; 14(17):1619-1629. PubMed ID: 33336592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.